John D. Ulm

Array ( [id] => 3773115 [patent_doc_number] => 05849898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'CD40 coding sequences' [patent_app_type] => 1 [patent_app_number] => 8/485447 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 33488 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849898.pdf [firstpage_image] =>[orig_patent_app_number] => 485447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304208 [patent_doc_number] => 06187748 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Uses of CD4-gamma2 and CD4-IgG2 chimeras' [patent_app_type] => 1 [patent_app_number] => 8/485372 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 32 [patent_no_of_words] => 17723 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187748.pdf [firstpage_image] =>[orig_patent_app_number] => 485372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4056382 [patent_doc_number] => 05863786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Nucleic acid encoding modified human tnf.alpha. (tumor necrosis factor alpha) receptor' [patent_app_type] => 1 [patent_app_number] => 8/465982 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 9262 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863786.pdf [firstpage_image] =>[orig_patent_app_number] => 465982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926281 [patent_doc_number] => 05945509 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Glutamate receptor compositions and method' [patent_app_type] => 1 [patent_app_number] => 8/486269 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 8 [patent_no_of_words] => 29571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945509.pdf [firstpage_image] =>[orig_patent_app_number] => 486269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764435 [patent_doc_number] => 05852167 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Totally synthetic affinity reagents' [patent_app_type] => 1 [patent_app_number] => 8/471800 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 41933 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852167.pdf [firstpage_image] =>[orig_patent_app_number] => 471800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035804 [patent_doc_number] => 05856296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'DNA encoding interleukin-4 receptors' [patent_app_type] => 1 [patent_app_number] => 8/466846 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 37 [patent_no_of_words] => 24939 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856296.pdf [firstpage_image] =>[orig_patent_app_number] => 466846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942625 [patent_doc_number] => 05998164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Polynucleotides encoding human G-protein coupled receptor GPRZ' [patent_app_type] => 1 [patent_app_number] => 8/467948 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23770 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998164.pdf [firstpage_image] =>[orig_patent_app_number] => 467948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656900 [patent_doc_number] => 05591590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Neuronal nicotinic acetylcholine receptor assay' [patent_app_type] => 1 [patent_app_number] => 8/472989 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 60 [patent_no_of_words] => 35202 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591590.pdf [firstpage_image] =>[orig_patent_app_number] => 472989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356791 [patent_doc_number] => 06255069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Compositions and methods for modulating the activity of G protein-coupled receptor kinases GPK5 and GRK6' [patent_app_type] => 1 [patent_app_number] => 8/464954 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 15860 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255069.pdf [firstpage_image] =>[orig_patent_app_number] => 464954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235584 [patent_doc_number] => 06090575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Polynucleotides encoding human G-protein coupled receptor GPR1' [patent_app_type] => 1 [patent_app_number] => 8/467947 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23329 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090575.pdf [firstpage_image] =>[orig_patent_app_number] => 467947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035827 [patent_doc_number] => 05856297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Human C3b/C4b receptor (CR1)' [patent_app_type] => 1 [patent_app_number] => 8/472038 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 81 [patent_no_of_words] => 45148 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856297.pdf [firstpage_image] =>[orig_patent_app_number] => 472038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3803320 [patent_doc_number] => 05830706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Polypeptide fusions to polypeptides of the beta-trefoil fold structural family' [patent_app_type] => 1 [patent_app_number] => 8/460915 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 39 [patent_no_of_words] => 14883 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830706.pdf [firstpage_image] =>[orig_patent_app_number] => 460915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014503 [patent_doc_number] => 06893845 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-17 [patent_title] => 'Surface expression libraries of heteromeric receptors' [patent_app_type] => utility [patent_app_number] => 08/471622 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11737 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/893/06893845.pdf [firstpage_image] =>[orig_patent_app_number] => 08471622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1123090 [patent_doc_number] => 06794160 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-21 [patent_title] => 'Hormone receptor compositions and methods' [patent_app_type] => B1 [patent_app_number] => 08/462817 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 95 [patent_no_of_words] => 46706 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794160.pdf [firstpage_image] =>[orig_patent_app_number] => 08462817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 488961 [patent_doc_number] => 07214511 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-08 [patent_title] => 'Hormone receptor compositions and methods' [patent_app_type] => utility [patent_app_number] => 08/464262 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 45 [patent_no_of_words] => 25059 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214511.pdf [firstpage_image] =>[orig_patent_app_number] => 08464262 [rel_patent_id] =>[rel_patent_doc_number] =>)